Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...
Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 ... pointing to a durable effect for a drug that could provide an alternative to injectables.
Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said in a news release. The agency's proposed order would remove oral phenylephrine from the "monograph" of ...
Broad-spectrum drugs may include bronchodilators ... treatments and possibly reduce need for other drugs, such as oral corticosteroids. An example of specific endotyping in current clinical ...
Using drugs changes a person's brain structure and functioning, particularly in areas involved in reward, stress, and self-control. These alterations make it harder for people to stop using substances ...